Tomasz Polanowski

591 total citations
10 papers, 441 citations indexed

About

Tomasz Polanowski is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Tomasz Polanowski has authored 10 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 1 paper in Pediatrics, Perinatology and Child Health. Recurrent topics in Tomasz Polanowski's work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Asthma and respiratory diseases (5 papers) and Respiratory Support and Mechanisms (4 papers). Tomasz Polanowski is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Asthma and respiratory diseases (5 papers) and Respiratory Support and Mechanisms (4 papers). Tomasz Polanowski collaborates with scholars based in Sweden, Germany and United Kingdom. Tomasz Polanowski's co-authors include Tobias Welte, Paul Hernandez, Romain Kessler, Marc Miravitlles, Stefan Peterson, Göran Eriksson, Lars Borgström, Tim Harrison, Thomas Larsson and Staffan Edsbäcker and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Respiratory Research.

In The Last Decade

Tomasz Polanowski

10 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Polanowski Sweden 6 421 339 14 11 9 10 441
Gonzalo de Miquel Spain 10 371 0.9× 300 0.9× 9 0.6× 9 0.8× 11 1.2× 24 407
В Е Ноников Russia 3 472 1.1× 401 1.2× 6 0.4× 14 1.3× 12 1.3× 5 494
Denise Till Switzerland 7 571 1.4× 489 1.4× 6 0.4× 16 1.5× 14 1.6× 11 595
Chris Compton United States 11 333 0.8× 270 0.8× 7 0.5× 3 0.3× 6 0.7× 29 345
R. Cameron United Kingdom 10 467 1.1× 382 1.1× 5 0.4× 8 0.7× 7 0.8× 14 506
Christie Arrasate United Kingdom 3 398 0.9× 307 0.9× 6 0.4× 13 1.2× 3 0.3× 6 411
Catherine Francisco Italy 4 610 1.4× 482 1.4× 7 0.5× 15 1.4× 8 0.9× 6 628
Ferran Chuecos Spain 9 295 0.7× 240 0.7× 6 0.4× 10 0.9× 9 1.0× 20 324
Ruby Birk United States 6 339 0.8× 258 0.8× 9 0.6× 13 1.2× 10 1.1× 14 349
S Menjoge United States 6 808 1.9× 629 1.9× 13 0.9× 22 2.0× 32 3.6× 6 867

Countries citing papers authored by Tomasz Polanowski

Since Specialization
Citations

This map shows the geographic impact of Tomasz Polanowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Polanowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Polanowski more than expected).

Fields of papers citing papers by Tomasz Polanowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Polanowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Polanowski. The network helps show where Tomasz Polanowski may publish in the future.

Co-authorship network of co-authors of Tomasz Polanowski

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Polanowski. A scholar is included among the top collaborators of Tomasz Polanowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Polanowski. Tomasz Polanowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Welte, Tobias, Marc Miravitlles, Paul Hernandez, et al.. (2009). ADDITION OF BUDESONIDE/FORMOTEROL TO TIOTROPIUM REDUCES THE NUMBER OF EXACERBATION DAYS COMPARED WITH TIOTROPIUM ALONE. CHEST Journal. 136(4). 26S–26S. 5 indexed citations
2.
Welte, Tobias, Marc Miravitlles, Paul Hernandez, et al.. (2009). Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 180(8). 741–750. 303 indexed citations
3.
Welte, Tobias, Marc Miravitlles, Paul Hernandez, et al.. (2009). BUDESONIDE/FORMOTEROL ADDED TO TIOTROPIUM PROVIDES RAPID IMPROVEMENTS IN LUNG FUNCTION AND ABILITY TO UNDERTAKE MORNING ACTIVITIES. CHEST Journal. 136(4). 24S–24S. 5 indexed citations
4.
5.
Partridge, Martyn R, et al.. (2009). Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. Therapeutic Advances in Respiratory Disease. 3(4). 147–157. 44 indexed citations
6.
7.
Welte, Tobias, Marc Miravitlles, Stefan Peterson, Tomasz Polanowski, & Romain Kessler. (2009). Budesonide/Formoterol Added to Tiotropium Improves the Management of COPD Patients.. A6192–A6192. 7 indexed citations
8.
Singh, Dave, et al.. (2007). Budesonide administered using chlorofluorocarbon and hydrofluoroalkane pressurized metered-dose inhalers: pharmacokinetics, pharmacodynamics and clinical equivalence. International Journal of Clinical Pharmacology and Therapeutics. 45(9). 485–495. 3 indexed citations
9.
Escribano, Amparo, et al.. (2006). Clinical comparability between the CFC and HFA budesonide pressurised metered-dose inhalers in paediatric patients with asthma: a randomised controlled trial. Current Medical Research and Opinion. 22(6). 1085–1092. 5 indexed citations
10.
Polanowski, Tomasz, Marcin Kurzyna, Paweł Kuca, et al.. (2000). [Differences in hemodynamics of thromboembolic and primary pulmonary hypertension].. PubMed. 104(5). 741–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gonzalo de Miquel Breakdown of academic impact, for papers by В Е Ноников Breakdown of academic impact, for papers by Denise Till Breakdown of academic impact, for papers by Chris Compton Breakdown of academic impact, for papers by R. Cameron Breakdown of academic impact, for papers by Christie Arrasate Breakdown of academic impact, for papers by Catherine Francisco Breakdown of academic impact, for papers by Ferran Chuecos Breakdown of academic impact, for papers by Ruby Birk Breakdown of academic impact, for papers by S Menjoge
Rankless by CCL
2026